Li Yu-Shan, Ren Qiang, Zhang Jian, Liang Yan-Chun, Han Ya-Ling, Zhang Quan-Yu
State Key Laboratory of Frigid Zone Cardiovascular Diseases, Department of Cardiology, The General Hospital of Northern Theater Command, 110016 Shenyang, Liaoning, China.
Postgraduate Training Base of The General Hospital of Northern Theater Command, Jinzhou Medical University, 110016 Shenyang, Liaoning, China.
Rev Cardiovasc Med. 2024 May 29;25(6):197. doi: 10.31083/j.rcm2506197. eCollection 2024 Jun.
Patients with coronary artery disease (CAD) often experience pulmonary ventilation dysfunction following their initial event. However, there is insufficient research exploring the relationship between this dysfunction and CAD prognosis.
To address this gap, a retrospective observational study was conducted involving 3800 CAD patients without prior pulmonary ventilation disease who underwent cardiopulmonary exercise testing (CPET) during hospitalization between November 2015 and September 2021. The primary endpoint was a composite of major adverse cardiovascular events (MACE), such as death, myocardial infarction (MI), repeat revascularization, and stroke. Propensity score matching (PSM) was used to minimize selection bias between the two groups, with a subgroup analysis stratified by smoking status.
The results showed that patients were divided into normal (n = 2159) and abnormal (n = 1641) groups based on their pulmonary ventilation function detected by CPET, with 1469 smokers and 2331 non-smokers. The median follow-up duration was 1237 (25-75% interquartile range 695-1596) days. The primary endpoint occurred in 390 patients (10.26%). 1472 patients in each of the two groups were enrolled in the current analysis after PSM, respectively. However, pulmonary function was not associated with MACE before (hazard ratio (HR) 1.20, 95% confidence interval (95% CI) 0.99-1.47; Log-rank = 0.069) or after PSM (HR 1.07, 95% CI 0.86-1.34; Log-rank = 0.545) among the entire population. Nonetheless, pulmonary ventilation dysfunction was significantly associated with an increased risk of MACE in smoking patients (HR 1.65, 95% CI 1.25-2.18; 0.001) but not in non-smoking patients (HR 0.81, 95% CI 0.60-1.09; = 0.159). In addition, there was a significant interaction between current smoking status and pulmonary ventilation dysfunction on MACE ( for interaction 0.001).
Pulmonary ventilation dysfunction identified through CPET was independently associated with long-term poor prognosis in smoking patients with CAD but not in the overall population.
冠心病(CAD)患者在初次发病后常出现肺通气功能障碍。然而,关于这种功能障碍与CAD预后之间的关系,目前的研究尚不充分。
为填补这一空白,我们进行了一项回顾性观察研究,纳入了3800例无既往肺通气疾病的CAD患者,这些患者于2015年11月至2021年9月住院期间接受了心肺运动试验(CPET)。主要终点是主要不良心血管事件(MACE)的复合终点,包括死亡、心肌梗死(MI)、再次血运重建和中风。采用倾向评分匹配(PSM)来尽量减少两组之间的选择偏倚,并按吸烟状态进行亚组分析。
结果显示,根据CPET检测的肺通气功能,患者被分为正常组(n = 2159)和异常组(n = 1641),其中吸烟者1469例,非吸烟者2331例。中位随访时间为1237(25%-75%四分位数间距695-1596)天。主要终点事件发生在390例患者中(10.26%)。PSM后,两组各有1472例患者纳入本分析。然而,在整个人群中,肺功能在PSM前后均与MACE无关(风险比(HR)1.20,95%置信区间(95%CI)0.99-1.47;Log秩检验=0.069)。尽管如此,肺通气功能障碍在吸烟患者中与MACE风险增加显著相关(HR 1.65,95%CI 1.25-2.18;P<0.001),而在非吸烟患者中则无此关联(HR 0.81,95%CI 0.60-1.09;P = 0.159)。此外,当前吸烟状态与肺通气功能障碍在MACE方面存在显著交互作用(交互作用P<0.001)。
通过CPET识别的肺通气功能障碍与吸烟的CAD患者的长期不良预后独立相关,但在总体人群中并非如此。